<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alhosan N</submitter><funding>Medical Research Council</funding><pagination>969-987</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618119</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>182(4)</volume><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>Fentanyls and nitazenes are μ-opioid receptor agonists responsible for a large number of opioid overdose deaths. Here, we determined the potency, dissociation kinetics and antagonism by naloxone at the μ receptor of several fentanyl and nitazene analogues, compared to morphine and DAMGO.&lt;h4>Experimental approach&lt;/h4>In vitro assays of G protein activation and signalling and arrestin recruitment were performed. AtT20 cells expressing μ receptors were loaded with a membrane potential dye and changes in fluorescence used to determine agonist potency, dissociation kinetics and susceptibility to antagonism by naloxone. BRET experiments were undertaken in HEK293T cells expressing μ receptors to assess Gi protein activation and β-arrestin 2 recruitment.&lt;h4>Key resul</pubmed_abstract><journal>British journal of pharmacology</journal><pubmed_title>Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ-opioid receptor.</pubmed_title><pmcid>PMC7618119</pmcid><funding_grant_id>MR/ S010890/1</funding_grant_id><funding_grant_id>MR/S010890/1</funding_grant_id><pubmed_authors>Kelly E</pubmed_authors><pubmed_authors>Henderson G</pubmed_authors><pubmed_authors>Santiago M</pubmed_authors><pubmed_authors>Alhosan N</pubmed_authors><pubmed_authors>Cavallo D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ-opioid receptor.</name><description>&lt;h4>Background and purpose&lt;/h4>Fentanyls and nitazenes are μ-opioid receptor agonists responsible for a large number of opioid overdose deaths. Here, we determined the potency, dissociation kinetics and antagonism by naloxone at the μ receptor of several fentanyl and nitazene analogues, compared to morphine and DAMGO.&lt;h4>Experimental approach&lt;/h4>In vitro assays of G protein activation and signalling and arrestin recruitment were performed. AtT20 cells expressing μ receptors were loaded with a membrane potential dye and changes in fluorescence used to determine agonist potency, dissociation kinetics and susceptibility to antagonism by naloxone. BRET experiments were undertaken in HEK293T cells expressing μ receptors to assess Gi protein activation and β-arrestin 2 recruitment.&lt;h4>Key resul</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-01T06:32:38.357Z</modification><creation>2026-04-08T10:02:43.716Z</creation></dates><accession>S-EPMC7618119</accession><cross_references><pubmed>39437833</pubmed><doi>10.1111/bph.17376</doi></cross_references></HashMap>